Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

Authors

Institutions

Publication Details

Journal
The Lancet Oncology
Published
2025-08-11
DOI
https://doi.org/10.1016/s1470-2045(25)00352-3
Citations
4
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
4.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

Erika Ruíz‐García, Joseph Chao, Qui Tran, Julien Taı̈eb et al.
4 citations
The Lancet Oncology
Colorectal Cancer Treatments and Studies
4.18
article

Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

Erika Ruíz‐García, Joseph Chao, Qui Tran, Julien Taı̈eb, Lisa Salvatore, D. Páez López-Bravo, Fausto Meriggi, Yasutoshi Kuboki, Taito Esaki, Dominik Paul Modest, David Cunningham, Marwan Fakih, Kun‐Huei Yeh, Filippo Pietrantonio, Chiara Cremolini, Michalis V. Karamouzis, Tae Won Kim, Emily Chan, István Májer
article en
4 citations

Abstract

No abstract available for this paper.
The Lancet OncologyVol. 26(9)
University of Pisa (IT), Ulsan College (KR), Royal Marsden NHS Foundation Trust (GB), Université Paris Cité (FR), Asan Medical Center (KR), Hospital de Sant Pau (ES), University of Ulsan (KR), National Hospital Organization Kyushu Cancer Center (JP), Electronic Sensor Technology (United States) (US), Hôpital Européen Georges-Pompidou (FR), City of Hope (US), National Taiwan University Hospital (TW), Health Economics and Outcomes Research (United Kingdom) (GB), National Cancer Center Hospital East (JP), Fondazione Poliambulanza Istituto Ospedaliero (IT), Instituto Nacional de Cancerología (MX), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Biostatistical Consulting (United States) (US)
Amgen Foundation
Good health and well-being
Openalex Percentile: Top 5%
Colorectal Cancer Treatments and Studies
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.